A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
Active, not recruiting · NCT03383458 · Registry updated 2026-07-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver cancer, liver disorder, neoplasm | Active, not recruiting | Phase 3 | 2026-07-31 | NCT03383458 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| Ono Pharmaceutical Co., Ltd. | 47 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Arizona Oncology Associates, PC - HOPE | Tucson | United States | 4 |
| Arkhangelsk Clinical Oncological Dispensary | Arkhangelsk | Russia | 4 |
| Chu Estaing | Clermont-Ferrand | France | 14 |
| Mayo Clinic in Arizona - Phoenix | Phoenix | United States | 11 |
| McGuire VA Medical Center | Richmond | United States | 4 |
| MetroHealth Medical Center | Cleveland | United States | 141 |
| Minnesota Oncology Hematology, P.A. | Minneapolis | United States | 9 |
| Sylvester Comprehensive Cancer Center/ UMHC | Miami | United States | 1 |
| Universitatsmedizin Mannheim | Mannheim | Germany | 1 |
| University of Michigan | Ann Arbor | United States | 538 |